Literature DB >> 27924556

In Vitro Enzyme Kinetics Analysis of EGFR.

Zhihong Wang1, Christine Candelora2.   

Abstract

The epidermal growth factor receptor (EGFR) is an essential receptor tyrosine kinase (RTK) that regulates cell proliferation and differentiation, and its abnormal activation contributes to a variety of human cancers. EGFR is activated by the binding of growth factors, such as epidermal growth factor (EGF), resulting in the formation of an asymmetric dimer in which one EGFR molecule allosterically activates the other molecule. This chapter provides a detailed protocol to purify and characterize full-length EGFR bound with EGF. This protocol facilitates the expression and preparation of full-length EGFR in transiently transfected mammalian cell culture. A method is also presented for quantitative evaluation of EGFR enzyme activity.

Entities:  

Keywords:  Epidermal growth factor receptor; Kinase assay; Mammalian protein expression; Radiometric assay; Transient transfection

Mesh:

Substances:

Year:  2017        PMID: 27924556     DOI: 10.1007/978-1-4939-6424-6_2

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Mechanism of BRAF Activation through Biochemical Characterization of the Recombinant Full-Length Protein.

Authors:  Nicholas Cope; Christine Candelora; Kenneth Wong; Sujeet Kumar; Haihan Nan; Michael Grasso; Borna Novak; Yana Li; Ronen Marmorstein; Zhihong Wang
Journal:  Chembiochem       Date:  2018-08-17       Impact factor: 3.164

Review 2.  Contributions of Thyroid Hormone to Cancer Metastasis.

Authors:  Shaker A Mousa; Gennadi V Glinsky; Hung-Yun Lin; Osnat Ashur-Fabian; Aleck Hercbergs; Kelly A Keating; Paul J Davis
Journal:  Biomedicines       Date:  2018-08-22

3.  EZH2 inhibitors reverse resistance to gefitinib in primary EGFR wild-type lung cancer cells.

Authors:  Hao Gong; Yongwen Li; Yin Yuan; Weiting Li; Hongbing Zhang; Zihe Zhang; Ruifeng Shi; Minghui Liu; Chao Liu; Chen Chen; Hongyu Liu; Jun Chen
Journal:  BMC Cancer       Date:  2020-12-04       Impact factor: 4.430

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.